EULAR 2026 European Congress of Rheumatology
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to EULAR 2026 European Congress of Rheumatology — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
EULAR 2026
Event type: Rheumatology, Immunology, Clinical Research, Medical Education, Healthcare Congress, Pharmaceutical & Medical Devices Networking
Estimated attendance: Typically a very large international medical congress format with thousands of healthcare professionals, researchers, industry representatives, and exhibitors. For planning purposes, this event should be treated as a global medical buyer and stakeholder gathering with strong purchasing influence from hospitals, pharmaceutical companies, device manufacturers, research institutions, and healthcare service providers.
Important note before final buyer selection: To give you the most accurate buyer list for attendee-list review, I should first review your client’s website and understand exactly what your client sells. The best buyer targets for this event change significantly depending on whether your client offers pharmaceuticals, diagnostics, lab equipment, medical devices, software, education, staffing, congress services, or healthcare marketing solutions.
Below is a deep research-style analysis structured for attendee-list buying and buyer targeting.
1️⃣ Who attends: Buyers / Attendees
EULAR 2026 is not a consumer show. It is a high-value professional medical congress focused on rheumatology and related musculoskeletal and autoimmune health topics. The attendee base is typically made up of decision-makers, senior clinicians, researchers, product specialists, and commercial teams working in the healthcare ecosystem.
The strongest attendee groups usually include:
- Rheumatologists, clinical immunologists, orthopedic specialists, internists, and pain-management physicians
- Hospital and clinic administrators responsible for service line decisions
- Researchers, professors, and academic physicians involved in autoimmune and inflammatory disease studies
- Pharma medical affairs, market access, and clinical development professionals
- Medical device and diagnostics company teams
- Health technology and digital health providers
- Patient advocacy organizations and nonprofit health groups
- Distributors and regional healthcare business development teams
From a buyer-list perspective, the most valuable contacts are not the general attendees alone, but the commercial, scientific, educational, and institutional decision-makers who attend to learn, network, partner, sponsor, or evaluate new treatment and research solutions.
2️⃣ Where the show is happening + attendee geographic origin
Show location: EULAR congresses are generally hosted in major European cities with international infrastructure. For the 2026 edition, the confirmed host city and venue should be validated from the official event website before final outreach segmentation.
Attendee geographic origin: This is a highly international event. Attendees typically come from:
- Europe-wide medical and research communities
- United Kingdom, Germany, France, Italy, Spain, Netherlands, Switzerland, Nordics, Benelux, and Central/Eastern Europe
- Middle East, North Africa, and selected Asian and North American healthcare markets
- Global pharmaceutical and healthcare companies with international product teams
Best geographic targeting:
- Primary: European Union and United Kingdom
- Secondary: Switzerland, Norway, Israel, UAE, Saudi Arabia, Turkey, Canada, and the United States
- Global companies with EMEA healthcare commercial teams
3️⃣ Audience reach
Reach type: Global
EULAR is a globally respected medical congress and should be treated as an international buyer environment. It is especially valuable for companies selling into:
- Rheumatology
- Autoimmune disease treatment
- Inflammatory disease research
- Biologics and specialty pharmaceuticals
- Diagnostics and biomarkers
- Hospital and clinic systems
- Medical education and scientific communications
This is not a local-only or national-only event. It has strong global relevance, and many exhibitors and attendees attend specifically to build cross-border scientific and commercial relationships.
4️⃣ Sample buyer company names + websites
Below is a sample buyer list that is more useful for attendee-list monetization than a generic exhibitor dump. These are companies and organizations that are typically relevant to a rheumatology / autoimmune / clinical research environment.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Roche | roche.com | Medical Affairs Director / Global Brand Lead / Immunology Marketing Manager | Major presence in specialty medicine, diagnostics, and research-driven healthcare markets. |
| 2 | AbbVie | abbvie.com | Therapeutic Area Lead / Medical Science Liaison Director / Market Access Manager | Strong fit for immunology, inflammation, and specialty pharma outreach. |
| 3 | Pfizer | pfizer.com | Medical Affairs Manager / Clinical Development Lead / Strategic Accounts Director | Large global pharmaceutical company with strong specialty medicine interest. |
| 4 | Novartis | novartis.com | Country Medical Director / Medical Advisor / External Affairs Manager | Relevant for immune-mediated disease, research, and physician education. |
| 5 | Sanofi | sanofi.com | Medical Lead / Market Development Manager / Scientific Engagement Manager | Strong healthcare portfolio and international commercial presence. |
| 6 | UCB | ucb.com | Rheumatology Brand Manager / Medical Affairs Lead | Highly relevant in immunology and specialty disease focus areas. |
| 7 | Eli Lilly and Company | lilly.com | Medical Affairs Director / Product Marketing Director | Strong fit for disease education, physician engagement, and specialty medicine. |
| 8 | Bristol Myers Squibb | bms.com | Scientific Communications Manager / Business Unit Director | Relevant for immunology, clinical research, and healthcare partnerships. |
| 9 | GSK | gsk.com | Medical Science Liaison Manager / Healthcare Partnerships Lead | Good fit for specialty medicine, vaccines, and life sciences engagement. |
| 10 | Johnson & Johnson | jnj.com | Strategic Account Manager / Medical Education Manager | Broad healthcare footprint, including medtech and pharma-linked engagement. |
| 11 | Amgen | amgen.com | Medical Affairs Lead / Scientific Director / Payer Strategy Manager | Biotech company with strong relevance to inflammatory and specialty care. |
| 12 | Boehringer Ingelheim | boehringer-ingelheim.com | Therapeutic Area Manager / Regional Medical Advisor | Strong global healthcare presence and deep scientific engagement needs. |
| 13 | Merck & Co. | merck.com | Clinical Strategy Manager / Medical Science Liaison Director | Relevant for research, healthcare professional engagement, and specialty strategy. |
| 14 | Thermo Fisher Scientific | thermofisher.com | Clinical Diagnostics Manager / Research Sales Director | Good fit for lab, diagnostics, and research infrastructure buyers. |
| 15 | Siemens Healthineers | siemens-healthineers.com | Hospital Sales Director / Clinical Applications Manager | Strong healthcare technology and diagnostic buyer profile. |
| 16 | Abbott | abbott.com | Diagnostics Marketing Manager / Hospital Account Executive | Relevant for diagnostics, testing, and hospital-based purchasing. |
| 17 | Takeda | takeda.com | Medical Affairs Lead / Global Evidence Generation Manager | Good fit for specialty therapies and global healthcare outreach. |
| 18 | Medtronic | medtronic.com | Clinical Specialist Manager / Commercial Director | Medical technology company with strong healthcare decision-maker relevance. |
| 19 | Philips | philips.com | Healthcare Solutions Manager / Enterprise Sales Director | Good fit for hospital technology, imaging, and digital healthcare conversations. |
| 20 | Sanofi Genzyme | sanofi.com | Rare Disease / Immunology Marketing Lead | Highly relevant to autoimmune, specialty care, and physician education audiences. |
Top 5 buyer companies to prioritize first: Roche, AbbVie, Pfizer, Novartis, Sanofi. These names give you the strongest mix of specialty pharma, global buying power, and relevance to rheumatology and immunology.
5️⃣ Job profiles, industries & event type
Best job profiles to target:
- Medical Affairs Director
- Medical Science Liaison
- Clinical Development Lead
- Therapeutic Area Manager
- Global Brand Manager
- Market Access Manager
- Scientific Communications Manager
- Healthcare Partnerships Director
- Hospital Account Manager
- Country Medical Director
- Research Program Manager
- Biomarker / Diagnostic Product Manager
- Clinical Operations Manager
- Medical Education Manager
- Regional Sales Director, Specialty Care
Best industries to use from your industry list:
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Hospital & Health Care
- Research
- Health, Wellness & Fitness
- Information Technology & Services
- Medical Practice
- Nonprofit Organization Management
- Education Management
- Higher Education
- Market Research
- Management Consulting
- Public Policy
- Professional Training & Coaching
Event type classification: This is a scientific congress with high commercial value. It is best positioned as a medical education and specialty healthcare event with strong pharma, biotech, diagnostics, and hospital buying influence.
6️⃣ Estimated attendance / expected footfall
While exact attendance can vary by city and year, EULAR congresses typically attract a large international audience. For planning and buyer-list purposes, it should be treated as a multi-thousand attendee event with meaningful participation from Europe and beyond.
Footfall logic:
- Large volume of clinicians and researchers
- Strong participation from pharma and medtech companies
- High density of exhibitors, sponsors, and scientific content attendees
- Decision-maker concentration is higher than at general healthcare expos
This is valuable because even if the event includes a broad scientific audience, the commercial buyer layer is substantial and highly targeted.
7️⃣ Key focus areas & buyer engagement
Key focus areas usually include:
- Rheumatoid arthritis
- Psoriatic arthritis
- Osteoarthritis
- Systemic lupus erythematosus
- Vasculitis
- Spondyloarthritis
- Autoimmune disease management
- Inflammation and immunology
- Biomarkers and diagnostics
- Real-world evidence and clinical research
- Treatment innovation and specialty therapies
- Patient outcomes and disease monitoring
Buyer engagement angles:
- Scientific updates and physician education
- Product awareness in specialty medicine
- Clinical trial and evidence-generation networking
- KOL engagement and congress sponsorship
- Hospital and clinic solution discussions
- Diagnostics and biomarker adoption
- Market access and payer strategy conversations
- International relationship building across EMEA and global markets
The strongest outreach message is not a generic attendee-list pitch. It should be framed around access to specialty healthcare decision-makers, medical affairs professionals, clinical researchers, and commercial healthcare buyers.
8️⃣ Client-product fit review: ask for the client website first
Before I finalize the best buyers for this event, I need your client’s website. That is the most important filter. Without it, the buyer list will be too broad and less useful.
Why this matters:
- If your client sells pharmaceutical services, the best targets are medical affairs, commercial leaders, and clinical teams.
- If your client sells medical devices or diagnostics, the right buyers may be hospital procurement, product managers, clinical specialists, and distributors.
- If your client sells marketing, data, or event services, then sponsor teams, congress managers, and healthcare communications leaders become the priority.
- If your client sells software or digital health tools, then hospital innovation leaders, research teams, and health-tech decision-makers are stronger prospects.
Best practice: Please share the client website, and I will then narrow this down to the most relevant buyer personas, the best company targets, and the most suitable industry filters.
9️⃣ Industry suggestions based on your industry list
For EULAR 2026, the most relevant industry selections from your list are:
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Hospital & Health Care
- Research
- Market Research
- Information Services
- Information Technology & Services
- Professional Training & Coaching
- Higher Education
- Education Management
- Management Consulting
- Health, Wellness & Fitness
- Public Policy
- Nonprofit Organization Management
Secondary industries may also apply depending on your client’s offer:
- Marketing & Advertising
- Public Relations & Communications
- Clinical Research organizations
- Laboratory services
- Healthcare software and analytics
- Medical education providers
Final recommendation
EULAR 2026 is a strong event for attendee-list selling if your client is aligned with healthcare, specialty medicine, diagnostics, medical technology, research, or professional healthcare communications. It is especially valuable because the audience includes high-quality professional buyers with influence over treatment strategy, scientific adoption, procurement, education, and market access.
Best buyer segments to prioritize:
- Medical Affairs and Scientific Affairs teams
- Therapeutic area leaders in rheumatology and immunology
- Clinical development and research professionals
- Diagnostics and biomarker companies
- Hospital and health system decision-makers
- Medical education and congress sponsorship teams
- Specialty pharma and biotech commercial teams
Quality rating for B2B attendee-list sales: 9/10
This is a high-value global medical congress with excellent buyer potential. The strongest results will come from filtering by role, therapeutic area, company type, and your client’s exact offering.
Next step: Share your client website, and I will review it and tell you the best buyers to target for EULAR 2026 based on exact product fit.
Data sheet
EULAR 2026 European Congress of Rheumatology – Event Attendee & Buyer Profile Analysis
Event date: 3 June 2026 – 6 June 2026
Location: ExCeL London, London, England, United Kingdom
Event status: Completed
Research date: 22 June 2026
Event Overview
| Event Name | EULAR 2026 European Congress of Rheumatology |
| Event Date | 3 June 2026 – 6 June 2026 |
| Event Status | Completed |
| Venue | ExCeL London |
| City | London |
| State / Region | England |
| Country | United Kingdom |
| Organizer | EULAR – European Alliance of Associations for Rheumatology |
| Official Event Website | congress.eular.org |
| Event Type | International medical congress, scientific meeting, clinical education forum, healthcare partnership and industry networking event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Education & Training; IT & Technology |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer for the 2026 edition at time of research. |
| Attendance Data Reliability | Current-year public count not confirmed. Prior editions indicate a large international rheumatology congress format with substantial clinical, research, and industry participation. |
| Main Purpose of Event | To convene rheumatology clinicians, researchers, patient advocates, healthcare organizations, pharmaceutical companies, medical device firms, digital health suppliers, and clinical education stakeholders for scientific exchange, commercial engagement, product visibility, and partnership development. |
About the Event
EULAR 2026 European Congress of Rheumatology is a major international congress centered on rheumatology, autoimmune and musculoskeletal disease management, clinical science, translational research, treatment innovation, and professional education. The event is organized by EULAR, a leading European rheumatology alliance, and is positioned as a high-value meeting point for physicians, hospital specialists, academics, allied health professionals, patient representatives, pharmaceutical companies, medical technology suppliers, and healthcare solution providers.
From a commercial and buyer-intelligence perspective, the congress matters because it attracts stakeholders with direct or indirect influence over prescribing pathways, clinical adoption, research collaboration, hospital evaluation, procurement discussions, medical education partnerships, and brand positioning in rheumatology. It is especially relevant for firms selling therapeutics, diagnostics, medical devices, digital health platforms, clinical trial services, research tools, patient support solutions, and specialist healthcare services.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Hospital rheumatologists and department leads | NHS trusts, university hospitals, specialist rheumatology centers, European hospital systems | Clinical evaluation, treatment pathway influence, formulary input, equipment and software recommendation | High relevance for therapies, diagnostics, imaging, monitoring tools, EMR-integrated solutions, education and support services |
| Clinical researchers and principal investigators | Universities, teaching hospitals, academic medical centers, research institutes | Trial participation, protocol influence, data generation, publication and KOL impact | Important for CROs, research platforms, biomarkers, lab tools, patient recruitment services, and industry partnerships |
| Pharmaceutical medical and commercial teams | Biopharma companies active in immunology, inflammation, biologics, biosimilars, rare disease and specialty medicine | Pipeline visibility, competitive intelligence, medical affairs engagement, partnership evaluation | Key audience for clinical services, launch support, market access, congress services, analytics, and physician engagement solutions |
| Medical device and diagnostics leaders | Imaging firms, testing providers, patient monitoring vendors, infusion and injection support companies | Product positioning, channel partnerships, hospital evaluation, specialist adoption | Relevant for OEM suppliers, distributors, software vendors, evidence-generation services and commercial partners |
| Procurement and supply chain teams | Hospitals, health systems, research organizations, pharma operations teams | Vendor qualification, sourcing, tender participation, budget review | Relevant for medical consumables, devices, software, logistics, managed services and support contracts |
| Digital health and health IT leaders | Digital therapeutics firms, hospital IT teams, patient engagement software providers, data platforms | Evaluation of interoperability, patient monitoring, registry support and workflow optimization | High relevance for SaaS, AI, analytics, telehealth, outcomes tracking and real-world evidence platforms |
| Patient organizations and advocacy groups | Disease associations, nonprofit organizations, patient alliances | Program partnership, awareness campaigns, support pathway influence | Useful for patient education, adherence services, communications, and community engagement programs |
| Association leaders and guideline contributors | Professional societies, specialist associations, working groups | Thought leadership, educational programming, influence over standards and visibility | Relevant for sponsors, education partners, CME providers, and clinical content vendors |
| Investors and strategic partners | Healthcare investors, strategic business development teams, licensing groups | Partnership, deal sourcing, portfolio scouting, innovation review | Relevant for biotech, medtech, health IT and research service companies seeking alliances |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: London | Local hospital specialists, UK-based pharma offices, medical societies, digital health firms, consultancies | High | London is a major healthcare, academic, pharmaceutical and life sciences hub with strong event accessibility |
| Host region: England | NHS trusts, university hospitals, research institutions, biotech and medtech stakeholders across England | High | Good domestic draw for clinicians, procurement-linked healthcare teams and academic researchers |
| United Kingdom | National clinical and research participants from England, Scotland, Wales and Northern Ireland | High | Likely strong attendance from specialist centers and professional societies |
| Europe | European rheumatology community, EU and non-EU hospitals, universities, research groups, industry teams | Very High | EULAR’s core constituency is pan-European, making Europe the dominant international source market |
| North America | Global pharma, biotech, medical device, academic and KOL participation | Medium to High | Important for multinational exhibitors, strategic alliances and scientific exchange |
| Middle East, Asia-Pacific and other international markets | Specialist clinicians, distributors, pharmaceutical regional teams, academics, partner organizations | Medium | Global congress profile supports cross-border attendance where rheumatology and immunology programs are active |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The event is internationally recognized and attracts clinical, research and industry stakeholders from across Europe and other global markets. |
| European | Strong secondary reach | EULAR’s organizational footprint and scientific mission make Europe the strongest attendee concentration. |
| United Kingdom | Important host-market reach | The London location increases participation from UK clinical, hospital, academic and life sciences organizations. |
4. Sample Buyer Companies and Websites
Current-year attendee and buyer organization lists were not publicly confirmed in the reviewed official event materials at time of research. The table below is a prospecting-oriented buyer sample based on strong market fit for EULAR’s rheumatology ecosystem. These are relevant organizations to target around the event, but their attendance is not confirmed unless specifically stated.
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| NHS England / NHS hospital trusts | Public healthcare buyer | Large end-user base for rheumatology care pathways, hospital systems, digital tools, diagnostics and patient services | england.nhs.uk | Clinical Director Rheumatology, Procurement Manager, Digital Health Lead, Head of Outpatients | Strong Market Fit, Attendance Not Confirmed |
| University College London Hospitals NHS Foundation Trust | Academic hospital buyer | Relevant London-based specialist hospital environment with research and rheumatology-related clinical activity | uclh.nhs.uk | Consultant Rheumatologist, Research Director, Procurement Lead, Innovation Lead | Strong Market Fit, Attendance Not Confirmed |
| Guy’s and St Thomas’ NHS Foundation Trust | Academic hospital buyer | Large tertiary care and research setting relevant for specialist treatment evaluation and digital care solutions | gstt.nhs.uk | Rheumatology Lead, Director of Research, Procurement Category Manager, Service Line Manager | Strong Market Fit, Attendance Not Confirmed |
| Oxford University Hospitals NHS Foundation Trust | Academic hospital buyer | Research-intensive clinical organization aligned with trial participation and specialist treatment pathways | ouh.nhs.uk | Consultant Rheumatologist, Clinical Trials Director, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Karolinska University Hospital | European specialist hospital buyer | High-fit academic and specialist care institution within the European clinical research ecosystem | karolinska.se | Head of Rheumatology, Research Group Lead, Procurement Specialist | Strong Market Fit, Attendance Not Confirmed |
| Charité – Universitätsmedizin Berlin | Academic medical center buyer | Major European clinical and research institution relevant for rheumatology innovation and collaboration | charite.de | Professor of Rheumatology, Clinical Research Lead, Category Buyer Medical | Strong Market Fit, Attendance Not Confirmed |
| Sanofi | Pharmaceutical buyer / partner | Relevant for immunology, specialty medicine, medical affairs, congress engagement and partnership discussions | sanofi.com | Medical Affairs Director, Congress Lead, Global Brand Director, Partnerships Director | Strong Market Fit, Attendance Not Confirmed |
| AbbVie | Pharmaceutical buyer / partner | Major rheumatology and immunology market participant relevant for therapy, medical education and ecosystem partnerships | abbvie.com | Medical Director, Market Access Director, Congress Strategy Lead, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Johnson & Johnson Innovative Medicine | Pharmaceutical buyer / partner | Relevant for immunology commercialization, clinical engagement and professional education partnerships | jnj.com | Immunology Franchise Lead, Medical Affairs Lead, HEOR Director, Congress Manager | Strong Market Fit, Attendance Not Confirmed |
| UCB | Biopharma buyer / partner | Specialty biopharma company relevant to inflammatory and immune-mediated disease engagement | ucb.com | Medical Director, Alliance Director, Clinical Partnerships Lead, Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| Pfizer | Pharmaceutical buyer / partner | Relevant for rheumatology, inflammatory disease and medical congress activity | pfizer.com | Therapeutic Area Lead, Medical Affairs Director, External Innovation Lead | Strong Market Fit, Attendance Not Confirmed |
| Roche | Pharma / diagnostics buyer | Relevant for autoimmune disease, diagnostics, evidence generation and strategic collaboration | roche.com | Medical Director, Diagnostics Partnerships Lead, Scientific Affairs Lead | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Head of Rheumatology | Clinical Services | Director / Department Head | Influences clinical adoption, departmental priorities and specialist supplier evaluation |
| 2 | Consultant Rheumatologist | Clinical Care | Senior Individual Contributor | Direct end-user and influential evaluator for therapies, diagnostics, monitoring and support tools |
| 3 | Medical Affairs Director | Medical Affairs | Director | Key for congress strategy, KOL engagement, evidence partnerships and scientific collaboration |
| 4 | Clinical Research Director / Principal Investigator | Research | Director / Senior Research Lead | Controls trial participation, research partnerships, and data-generation opportunities |
| 5 | Procurement Manager | Procurement | Manager | Relevant for sourcing decisions involving devices, digital platforms, consumables and support services |
| 6 | Category Manager, Medical / Diagnostics | Strategic Sourcing | Manager | Important for formal buying cycles, tenders and vendor framework decisions |
| 7 | Digital Health Lead / Clinical Informatics Lead | Health IT | Manager / Director | Owns adoption of remote monitoring, patient engagement, analytics and interoperability tools |
| 8 | Market Access Director | Commercial / Access | Director | Relevant for partnerships tied to outcomes, value demonstration and healthcare system uptake |
| 9 | Business Development Director | Partnerships | Director | Key for strategic alliances, co-development, distribution and channel expansion |
| 10 | Congress Manager / Events Lead | Commercial Operations / Events | Manager | Relevant for exhibit, sponsorship, event services and engagement program buying |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core buyer group for specialist care delivery and solution adoption | Hospitals, clinics, trust networks, specialist treatment centers |
| 2 | Pharmaceuticals | Major commercial presence in rheumatology and immunology | Medical affairs, congress engagement, clinical partnerships, market access |
| 3 | Biotechnology | Strong fit for immunology, specialty medicine and research-led companies | Licensing, trials, scientific collaboration, launch planning |
| 4 | Medical Devices | Relevant for diagnostics, monitoring and specialist care tools | Clinical adoption, hospital evaluation, distribution partnerships |
| 5 | Research | Academic and translational research participation is central to congress value | Trial sites, registries, studies, collaborative projects |
| 6 | Higher Education | Medical schools and universities contribute investigators and educators | Research collaborations, education platforms, grants and services |
| 7 | Information Technology & Services | Supports digital health, data, analytics and interoperability use cases | Patient monitoring, analytics, clinical workflow software |
| 8 | Computer Software | Useful for SaaS vendors addressing registry, research and patient engagement needs | Clinical data platforms, engagement apps, decision support tools |
| 9 | Government Administration | Public health systems and agency stakeholders may influence reimbursement and care pathways | Health system partnerships, public service programs, access initiatives |
| 10 | Nonprofit Organization Management | Patient associations and alliances play a visible role in rheumatology ecosystems | Advocacy partnerships, patient support, education campaigns |
| 11 | Health, Wellness & Fitness | Relevant for rehabilitation, patient support and lifestyle-adjacent care offerings | Support programs, adherence tools, wellness interventions |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer | Not confirmed | Official public event information reviewed | Congress format and EULAR brand suggest a large-scale international audience, but no public 2026 count was verified |
| Exhibitor count | Not publicly confirmed | Not confirmed | Official event materials reviewed | Industry exhibition is expected, but no verified public count was available at time of research |
| Buyer count | Not publicly confirmed | Not confirmed | No official buyer list released publicly | This is a congress, not a pure hosted-buyer event; buying influence is distributed across clinical, research and industry audiences |
| Speaker count | Not publicly confirmed in this report | Not confirmed | Agenda and faculty details may be available on official program pages | A full faculty roster typically exists for major congresses, but a consolidated validated count was not used here |
| Sponsor count | Not publicly confirmed in this report | Not confirmed | Official sponsorship/exhibition information may exist | Useful for sales prioritization if official sponsor pages are shared later |
| Historical attendance | Large international congress format | Historical / prior-year evidence | Prior EULAR congress reputation and event positioning | Appropriate to treat as a high-value global rheumatology stakeholder gathering for planning and targeting |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Rheumatology therapeutics | Clinical efficacy, safety, patient adherence, new treatment options | Medical affairs meetings, investigator discussions, scientific exchange | Therapies, adherence support, market access services, medical education |
| Clinical research | Trial participation, data quality, patient recruitment, registry support | Research collaboration, study feasibility, site expansion | CRO support, eClinical tools, data platforms, lab and biomarker services |
| Diagnostics and monitoring | Disease assessment, monitoring progression, workflow integration | Product demos, pilot discussions, hospital evaluation | Diagnostic tools, imaging support, patient monitoring platforms |
| Digital transformation | Remote patient management, data capture, interoperability, analytics | IT leadership outreach, pilot programs, proof-of-concept discussions | SaaS platforms, patient apps, AI analytics, workflow automation |
| Medical education | Clinical updates, guideline dissemination, peer learning | Sponsored symposia, CME collaboration, content partnerships | Education services, content production, speaker support, digital learning |
| Patient support and outcomes | Adherence, quality of life, engagement, access support | Partnerships with providers, pharma and advocacy groups | Patient services, support programs, digital coaching, advocacy campaigns |
| Partnership and licensing | Pipeline access, strategic alliances, channel expansion | Executive meetings, alliance development, co-commercialization discussions | Business development, in-licensing, distribution, co-development services |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Strong fit for clinical buyers, medical affairs teams, researchers, hospital stakeholders and specialist healthcare suppliers |
| Decision-maker availability | High | Congresses of this type typically gather senior clinicians, investigators, brand leaders and functional decision-makers |
| Data collection potential | Medium | Public attendee lists are usually limited; sponsor, speaker, abstract and exhibitor ecosystem data are more accessible than a full delegate roster |
| Apollo targeting potential | Very High | Clear targeting exists across hospitals, pharma, biotech, medtech, research institutes and health IT vendors |
| Geographic targeting potential | High | Europe should be primary, with UK, Germany, France, Spain, Italy, Nordics, Benelux and selected global life-science hubs as secondary targets |
| Best outreach approach | High | Use disease-area relevance, scientific value, patient outcomes, workflow improvement and evidence-led messaging rather than generic event follow-up |
| Overall lead quality | High | Particularly strong for specialized healthcare, biopharma, medtech, digital health and research-service offers |
| Best use case | High | Excellent for B2B attendee-list building through surrounding ecosystem mapping, exhibitor/sponsor follow-up, KOL targeting and clinical-account prospecting |
| Limitations / risks | Medium | Delegate privacy, compliance considerations, and incomplete public confirmation of attendee rosters may limit certainty of current-year attendance claims |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Biotechnology; Medical Devices; Research; Higher Education; Information Technology & Services; Computer Software; Government Administration; Nonprofit Organization Management | Build the highest-fit target universe around rheumatology care, science and commercial ecosystems |
| Departments | Medical Affairs; Research; Clinical Operations; Procurement; Supply Chain; Information Technology; Business Development; Partnerships; Marketing; Operations | Focus on roles with influence over evaluation, adoption, partnerships and event engagement |
| Seniority | Manager; Director; VP; CXO; Partner; Head | Prioritize decision-makers and budget influencers |
| Job titles | Head of Rheumatology; Consultant Rheumatologist; Medical Affairs Director; Clinical Research Director; Principal Investigator; Procurement Manager; Category Manager Medical; Digital Health Lead; Market Access Director; Business Development Director; Congress Manager | Align outreach with clinical, commercial and partnership authority |
| Geography | United Kingdom; Germany; France; Italy; Spain; Netherlands; Belgium; Sweden; Switzerland; Denmark; Ireland; selected North America life-science hubs | Mirror likely EULAR participation footprint and strongest commercial relevance |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Cover specialist biotechs through large health systems and multinational pharma companies |
| Keywords | rheumatology, immunology, autoimmune, inflammatory disease, musculoskeletal, arthritis, biologics, biosimilars, real-world evidence, patient support, digital therapeutics, clinical trials | Refine accounts and contacts tied to the congress disease area |
| Technologies, if relevant | EHR, patient engagement platform, remote monitoring, analytics, registry software, clinical trial software | Useful for health IT and digital health sales motions |
| Revenue range, if relevant | Mid-market to enterprise where available | Prioritize organizations with budget capacity for specialist healthcare solutions |
| Company type | Public; Private; Nonprofit; Government; Academic | Reflects the multi-stakeholder structure of EULAR’s audience |
Suggested Apollo Search Logic: Use account keywords such as “rheumatology” OR “immunology” OR “autoimmune” OR “arthritis” OR “inflammatory disease” OR “musculoskeletal” and pair with title filters such as “medical affairs” OR “rheumatologist” OR “clinical research” OR “procurement” OR “digital health” OR “market access” OR “business development.” Prioritize Europe-first account lists, then expand to global pharma, biotech and academic centers active in immunology.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| EULAR Congress official website | Official event website | Event identity, congress branding, official dates and core positioning | High |
| EULAR official organization website | Organizer website | Organizer name, association scope, rheumatology mission and event ownership | High |
| ExCeL London venue website | Official venue website | Venue identity and London location details | High |
| Official public event pages reviewed at time of research | Verification note | No public current-year attendance count, buyer list or consolidated exhibitor count was confirmed in this report | High transparency / limited public detail |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to EULAR 2026 European Congress of Rheumatology — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds